[1]
Talaie, H. et al. 2019. High sensitivity versus low level of vancomycin needs to be concern for another alternative anti- Staphylococcus aureus as the first- line antibiotic. Acta Biomedica Atenei Parmensis. 90, 4 (Dec. 2019), 498–503. DOI:https://doi.org/10.23750/abm.v90i4.7646.